While activated CD4+ T helper 2 (Th2) cells and regulatory T (Treg) cells promote tumor-induced immunosuppression, CD4+ T helper 17 (Th17) cells either support or inhibit tumor progression, depending on the context [80]. The gene discussed is CD4; the disease is neoplasm.